Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
October 01, 2024 16:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and...
Kronos Advanced Technologies Inc. and Yasheng Group Announce Key Milestone in Nuclear Battery Collaboration with Provisional Patent Filing
September 27, 2024 10:30 ET
|
Kronos Advanced Technologies Inc.
Parkersburg, WV, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Advanced Technologies Inc. (OTC: KNOS) and Yasheng Group (OTC: HERB) are proud to announce significant progress in their ongoing...
Cayosoft Wins Patent for Revolutionary Instant Active Directory Recovery Solution
September 24, 2024 09:00 ET
|
Cayosoft
COLUMBUS, Ohio, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cayosoft Inc., the leader in Microsoft Active Directory management, monitoring, and recovery, has secured the patent for its flagship product,...
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs)
September 24, 2024 08:00 ET
|
Araris Biotech
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs) AU ZH, SWITZERLAND,...
Black Kite Announces Court Dismissal of Bitsight Technologies’ Patent Claims in Federal Court Litigation
September 23, 2024 16:48 ET
|
Black Kite
BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Black Kite, the leader in third-party cyber risk intelligence, today announced that on September 20, 2024, in the United States District Court for the...
ImmuneSensor Therapeutics Granted New U.S. Patent for its Oral cGAS Inhibitors
September 17, 2024 08:00 ET
|
ImmuneSensor Therapeutics
Composition and methods patent granted claims covering compounds for treating broad range of inflammatory and autoimmune diseases and built on foundational intellectual property for the discovery of...
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
September 06, 2024 07:55 ET
|
Clearmind Medicine Inc.
Pioneering Therapeutic Approach Aims to Enhance Safety and Efficacyin Mental Health and Addiction Treatments Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
September 06, 2024 07:55 ET
|
SciSparc Ltd
Pioneering Therapeutic Approach Aims to Enhance Safety and Efficacy in Mental Health and Addiction Treatments TEL AVIV, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC)...
Rail Vision Granted U.S. Patent for AI-Powered Railway Obstacle Detection System, Revolutionizing Rail Safety
September 05, 2024 08:25 ET
|
Rail Vision Ltd.
Ra’anana, Israel, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related...
HydroGraph Announces Two Patent Application Filings for its Innovative Graphene Application
September 04, 2024 07:30 ET
|
Hydrograph Clean Power Inc.
HydroGraph Clean Power Inc. has announced the filing of two new US patent applications for graphene-coated hollow glass microsphere technology.